Across Study
Recruiting
- Conditions
- Psychiatric disorders
- Registration Number
- NL-OMON26462
- Lead Sponsor
- Amsterdam University Medical Center, AMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 2184
Inclusion Criteria
1. Ability to give informed consent
2. DSM-IV-TR axis I or DSM-5 diagnosis
3. Aged 14 – 75 years at intake
4. For under-aged participants, consent will also be obtained from the participant’s parents in addition to the participant’s consent
5. Fluent in Dutch
6. Clinically stable
Exclusion Criteria
1. High risk of suicide
2. Unstable medical disorder
3. Premorbid IQ < 70
4. History of a clinically significant abnormality of the neurological system (including dementia and other cognitive disorders or significant head injury) or any history of seizure (excluding febrile seizure)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure is cognitive functioning as assessed by the Cambridge Neuropsychological Test Automated Battery (CANTAB).
- Secondary Outcome Measures
Name Time Method The secondary outcome measures include the clinical symptoms, electro-encephalogram, genetic- and blood markers, hair cortisol.